Suppr超能文献

用Architect ci8200 上的颗粒增强散射免疫比浊法测定尿胱抑素 C。

Measurement of urinary cystatin C with a particle-enhanced turbidimetric immunoassay on Architect ci8200.

机构信息

Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.

出版信息

J Clin Lab Anal. 2012 Sep;26(5):358-64. doi: 10.1002/jcla.21531.

Abstract

BACKGROUND

Cystatin C is a low-molecular-weight protein that is freely filtered by the glomerulus and catabolized after reabsorption by the proximal tubular cells in healthy subjects. Urinary cystatin C is a potential biomarker for tubular damage including acute kidney injury (AKI) in the acute phase when patients are submitted to the intensive care unit.

METHODS

The aim of this study was to perform a method validation of urinary analysis of cystatin C by particle-enhanced turbidimetric immunoassay (PETIA) on a high-throughput chemical analyzer. Total assay time was 10 min. The antigen excess, linearity, lower limit of quantification (LoQ), recovery, assay precision, stability, and interference caused by hemoglobin were evaluated.

RESULTS

The LoQ was calculated to 0.020 mg/l with a coefficient of variation (CV) ≤ 10%. No hook effect was observed and the assay was linear over the studied interval less than 0.020-0.950 mg/l with a regression of R² = 0.9994. The assay had a recovery between 93-100% and the assay precision had a total CV of less than 3.5%. Cystatin C was stable for 3 days in room temperature and 14 days in +4C. The assay did not show any major interference with hemoglobin at a hemoglobin concentration of 10 g/L. The reference interval for urine cystatin C was less than 0.166 mg/l.

CONCLUSION

The urinary cystatin C PETIA showed good precision and performance characteristics including short test turnaround times that are necessary qualifications for a biomarker at a routine laboratory.

摘要

背景

胱抑素 C 是一种低分子量蛋白质,在健康受试者中可自由通过肾小球滤过,在近端肾小管细胞重吸收后被分解代谢。尿胱抑素 C 是一种潜在的生物标志物,可用于检测包括急性肾损伤(AKI)在内的管状损伤,尤其适用于处于重症监护病房的患者。

方法

本研究旨在对高通量化学分析仪上基于颗粒增强散射比浊免疫测定法(PETIA)的尿胱抑素 C 分析进行方法验证。总检测时间为 10 分钟。评估了抗原过剩、线性、定量下限(LoQ)、回收率、检测精密度、稳定性以及血红蛋白引起的干扰。

结果

LoQ 计算为 0.020mg/L,变异系数(CV)≤10%。未观察到钩状效应,检测在研究区间内呈线性,小于 0.020-0.950mg/L,回归 R²=0.9994。回收率在 93-100%之间,检测精密度总 CV 小于 3.5%。胱抑素 C 在室温下稳定 3 天,在+4°C 下稳定 14 天。在血红蛋白浓度为 10g/L 时,该检测不会对血红蛋白产生明显干扰。尿胱抑素 C 的参考区间小于 0.166mg/L。

结论

尿胱抑素 C 的 PETIA 具有良好的精密度和性能特征,包括较短的检测周转时间,这是常规实验室生物标志物的必要条件。

相似文献

2
Measurement of cystatin C in human urine by particle-enhanced turbidimetric immunoassay on an automated biochemistry analyzer.
Clin Biochem. 2013 Aug;46(12):1128-1130. doi: 10.1016/j.clinbiochem.2013.05.072. Epub 2013 Jun 12.
3
Particle enhanced turbidimetric immunoassay for the determination of urine cystatin C on Cobas c501.
Clin Biochem. 2012 Mar;45(4-5):339-44. doi: 10.1016/j.clinbiochem.2011.12.027. Epub 2012 Jan 12.
4
Analytical performances of PENIA and PETIA urinary cystatin C determination allow tubular injury investigation.
Ann Clin Biochem. 2019 Mar;56(2):228-231. doi: 10.1177/0004563218816341. Epub 2018 Dec 13.
6
Performance characteristics of a cystatin C immunoassay with avian antibodies.
Ups J Med Sci. 2007;112(1):21-37. doi: 10.3109/2000-1967-092.
7
Cystatin C analysis in the dog: a comparison of turbidimetric and nephelometric assay results.
Acta Vet Hung. 2010 Mar;58(1):59-67. doi: 10.1556/AVet.58.2010.1.6.
10
Performance evaluation of a particle-enhanced turbidimetric cystatin C assay on the Abbott ci8200 analyzer.
Clin Biochem. 2009 Jun;42(9):873-6. doi: 10.1016/j.clinbiochem.2009.02.024. Epub 2009 Mar 10.

引用本文的文献

本文引用的文献

1
Pathophysiology of ischemic acute kidney injury.
Nat Rev Nephrol. 2011 Apr;7(4):189-200. doi: 10.1038/nrneph.2011.16. Epub 2011 Mar 1.
2
Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.
J Korean Med Sci. 2011 Feb;26(2):258-63. doi: 10.3346/jkms.2011.26.2.258. Epub 2011 Jan 24.
3
Urinary excretion of twenty peptides forms an early and accurate diagnostic pattern of acute kidney injury.
Kidney Int. 2010 Dec;78(12):1252-62. doi: 10.1038/ki.2010.322. Epub 2010 Sep 8.
4
Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury.
Clin J Am Soc Nephrol. 2010 Dec;5(12):2154-65. doi: 10.2215/CJN.00740110. Epub 2010 Aug 26.
7
Serum and urinary biomarkers of acute kidney injury.
Blood Purif. 2010;29(4):357-65. doi: 10.1159/000309421. Epub 2010 Apr 14.
8
Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery.
Clin J Am Soc Nephrol. 2009 May;4(5):873-82. doi: 10.2215/CJN.04810908. Epub 2009 Apr 30.
9
Performance evaluation of a particle-enhanced turbidimetric cystatin C assay on the Abbott ci8200 analyzer.
Clin Biochem. 2009 Jun;42(9):873-6. doi: 10.1016/j.clinbiochem.2009.02.024. Epub 2009 Mar 10.
10
Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients.
AIDS. 2009 Jan 14;23(2):257-9. doi: 10.1097/QAD.0b013e328314e382.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验